1. Home
  2. GNLN vs LYRA Comparison

GNLN vs LYRA Comparison

Compare GNLN & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLN
  • LYRA
  • Stock Information
  • Founded
  • GNLN 2005
  • LYRA 2005
  • Country
  • GNLN United States
  • LYRA United States
  • Employees
  • GNLN N/A
  • LYRA N/A
  • Industry
  • GNLN Durable Goods
  • LYRA Medical/Dental Instruments
  • Sector
  • GNLN Consumer Discretionary
  • LYRA Health Care
  • Exchange
  • GNLN Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • GNLN 12.9M
  • LYRA 15.0M
  • IPO Year
  • GNLN 2019
  • LYRA 2020
  • Fundamental
  • Price
  • GNLN $3.81
  • LYRA $9.15
  • Analyst Decision
  • GNLN
  • LYRA Buy
  • Analyst Count
  • GNLN 0
  • LYRA 2
  • Target Price
  • GNLN N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • GNLN 2.3M
  • LYRA 288.0K
  • Earning Date
  • GNLN 08-13-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • GNLN N/A
  • LYRA N/A
  • EPS Growth
  • GNLN N/A
  • LYRA N/A
  • EPS
  • GNLN N/A
  • LYRA N/A
  • Revenue
  • GNLN $9,818,000.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • GNLN $1,541.21
  • LYRA N/A
  • Revenue Next Year
  • GNLN N/A
  • LYRA $1,286.17
  • P/E Ratio
  • GNLN N/A
  • LYRA N/A
  • Revenue Growth
  • GNLN N/A
  • LYRA N/A
  • 52 Week Low
  • GNLN $2.86
  • LYRA $3.81
  • 52 Week High
  • GNLN $16,350.00
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • GNLN 30.25
  • LYRA 44.26
  • Support Level
  • GNLN $3.65
  • LYRA $8.35
  • Resistance Level
  • GNLN $7.47
  • LYRA $9.36
  • Average True Range (ATR)
  • GNLN 1.70
  • LYRA 1.25
  • MACD
  • GNLN 2.20
  • LYRA -0.72
  • Stochastic Oscillator
  • GNLN 11.32
  • LYRA 9.95

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: